KEY FEATURES
Full Name | Vascular Endothelial Growth Factor C |
---|---|
Synonym | VEGF-C; Flt4-L; VRPL; Vascular Endothelial Growth Factor-Related Protein |
Assay Type | Sandwich |
Reactivity | Rat |
Range | 15.6-1000pg/mL |
Sensitivity | 6.6pg/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Rat VEGFC in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Rat VEGFC. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Rat VEGFC and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Rat VEGFC, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Rat VEGFC. You can calculate the concentration of Rat VEGFC in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Rat VEGFC ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 52.05 | 141.14 | 346.12 | 47.85 | 140.84 | 362.93 |
Standard deviation | 2.62 | 6.61 | 10.9 | 3.02 | 6.35 | 15.57 |
CV(%) | 5.04 | 4.68 | 3.15 | 6.32 | 4.51 | 4.29 |
RECOVERY
The recovery of Rat VEGFC spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 89-101 | 96 |
EDTA plasma (n=8) | 92-104 | 98 |
Cell culture media (n=8) | 85-97 | 90 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Rat VEGFC in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with VEGFC ELISA Kits
LYVE1 ELISA Kit | publications with VEGFC and LYVE1 |
FLT4 ELISA Kit | publications with VEGFC and FLT4 |
KDR ELISA Kit | publications with VEGFC and KDR |
PDPN ELISA Kit | publications with VEGFC and PDPN |
EGFR ELISA Kit | publications with VEGFC and EGFR |
FLT1 ELISA Kit | publications with VEGFC and FLT1 |
IGF1R ELISA Kit | publications with VEGFC and IGF1R |
FN1 ELISA Kit | publications with VEGFC and FN1 |
SERPINE1 ELISA Kit | publications with VEGFC and SERPINE1 |
Pathways associated with VEGFC ELISA Kit
Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
Focal Adhesion Pathway | Focal Adhesion Pathway |
Heart Development Pathway | Heart Development Pathway |
Hemostasis Pathway | Hemostasis Pathway |
PI3K-Akt Signaling Pathway | PI3K-Akt Signaling Pathway |
Pathways In Cancer | Pathways In Cancer |
Diseases associated with VEGFC ELISA Kit
Neoplasm Metastasis | publications with VEGFC and Neoplasm Metastasis |
Breast Neoplasms | publications with VEGFC and Breast Neoplasms |
Lung Neoplasms | publications with VEGFC and Lung Neoplasms |
Neoplasms, Experimental | publications with VEGFC and Neoplasms, Experimental |
Inflammation | publications with VEGFC and Inflammation |
Melanoma | publications with VEGFC and Melanoma |
Cardiovascular Diseases | publications with VEGFC and Cardiovascular Diseases |
Hyperplasia | publications with VEGFC and Hyperplasia |
Edema | publications with VEGFC and Edema |
Skin Neoplasms | publications with VEGFC and Skin Neoplasms |
Organs/Tissues associated with VEGFC ELISA Kit
Vascular | publications with VEGFC and Vascular |
Lung | publications with VEGFC and Lung |
Skin | publications with VEGFC and Skin |
Bone | publications with VEGFC and Bone |
Embryonic Tissue | publications with VEGFC and Embryonic Tissue |
Bone Marrow | publications with VEGFC and Bone Marrow |
Kidney | publications with VEGFC and Kidney |
Placenta | publications with VEGFC and Placenta |
Uterus | publications with VEGFC and Uterus |
Bladder | publications with VEGFC and Bladder |